ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,307.01
-0.27%
Dow Jones
39,671.04
-0.51%
US Dollar vs MXN
16.6491
-0.09%
Brent Oil
81.475
-0.07%
Bitcoin
69,606.71
0.73%
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NYSE
  6. Chemours Company (CC)

  7. Chemours Company (CC) Noticias

CC Chemours Company

27.15
-0.64 (-2.30%)
22 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Chemours Company CC NYSE Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
-0.64 -2.30% 27.15 16:30:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
27.49 26.995 27.65 27.15 27.79
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
14/5/202404:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
10/5/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/5/202415:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/5/202415:15EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
07/5/202404:45PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
03/5/202412:22PRNUSThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff..
02/5/202405:45BWChemours Discontinues U.S. Sales of Legacy Freon™..
30/4/202415:30BWThe Chemours Company Reports First Quarter 2024 Results
29/4/202415:15BWChemours Announces Second Quarter Dividend
26/4/202404:45PRNUSMay 20, 2024 Deadline: Contact The Gross Law Firm to Join..
24/4/202415:15BWChemours Announces Dates for First Quarter 2024 Earnings..
19/4/202404:50PRNUSInvestors who lost money on The Chemours Company(CC) should..
16/4/202404:50PRNUSThe Gross Law Firm Notifies Shareholders of The Chemours..
12/4/202404:45PRNUSThe Gross Law Firm Notifies Shareholders of The Chemours..
09/4/202405:00PRNUSClass Action Filed Against The Chemours Company (CC) Seeking..
05/4/202404:45PRNUSThe Gross Law Firm Reminds The Chemours Company Investors of..
04/4/202405:45BWChemours Recognized With Two Awards From U.S. Department of..
28/3/202408:48IHMARKETNEWSWalgreens Slashes Annual Profit Forecast; MillerKnoll..
27/3/202416:30BWChemours Announces Completion of Planned Procedures by the..
27/3/202416:25BWThe Chemours Company Reports Fourth Quarter and Full Year..
27/3/202407:00PRNUSDICELLO LEVITT LLP ANNOUNCES INVESTOR CLASS ACTION LAWSUIT..
26/3/202415:45BWChemours Announces Dates for Fourth Quarter 2023 Earnings..
22/3/202415:45BWChemours Announces Appointment of Denise Dignam as President..
20/3/202405:45BWChemours and Partners Selected for $60M in U.S. Department..
18/3/202416:16BWChemours Receives NYSE Notice Regarding Delayed Form 10-K..
06/3/202419:30BWChemours Provides Update on Internal Review
06/3/202416:32EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
05/3/202418:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202418:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
29/2/202407:19EDGAR2Form NT 10-K - Notification of inability to timely file Form..
29/2/202407:17EDGAR2Form 8-K - Current report
29/2/202407:14EDGAR2Form 8-K - Current report
28/2/202423:21BWCORRECTING and REPLACING Chemours Announces Management..
28/2/202421:14BWChemours Announces Management Actions and Delay of Form..
16/2/202415:17EDGAR2Form 8-K/A - Current report: [Amend]
16/2/202415:16EDGAR2Form 8-K - Current report
16/2/202407:30BWChemours Announces Changes to its Board of Directors

Su Consulta Reciente

NYSE
CC
Chemours
TSX
LIFE.B
Evolve Global Healthcare...
BIT
P1WAK4
NLBNPIT1WAK4 20240920 1.12
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados